Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence

JW Feng, J Ye, WX Wu, Z Qu, AC Qin… - Journal of Endocrinological …, 2020 - Springer
… that the increase of thyroid cancer was mainly accounted for the increased incidence of
papillary thyroid microcarcinoma (PTMC), which defined as papillary thyroid carcinoma (PTC) of …

Predicting the factors associated with central lymph node metastasis in clinical node-negative (cN0) papillary thyroid microcarcinoma

C Zhang, B Li, Z Liu, L Wang, W Cheng - European Archives of Oto-Rhino …, 2020 - Springer
… A case of papillary thyroid microcarcinoma (PTMC) with central lymph node metastasis and
… dissection and pathology showed papillary thyroid microcarcinoma and central lymph node …

[HTML][HTML] Analysis of the risk factors for central lymph-node metastasis of cN0 papillary thyroid microcarcinoma: A retrospective study

J Liu, XF Fan, M Yang, LP Huang - Asian Journal of Surgery, 2022 - Elsevier
… some patients with CLN-negative (cN0) papillary thyroid microcarcinoma (PTMC), while the
… of CLNM in patients with cN0 PTMC, contributing to screening cN0 PTMC patients with high …

[HTML][HTML] Predictors and a prediction model for central cervical lymph node metastasis in papillary thyroid carcinoma (cN0)

X Gao, W Luo, L He, J Cheng, L Yang - Frontiers in endocrinology, 2022 - frontiersin.org
Papillary thyroid carcinoma (PTC) is the most common endocrine carcinoma. Over the
past 30 years, the morbidity of thyroid carcinoma has doubled or more in many countries, …

Preoperative risk factors and recommendations for surgical intervention in cN0 papillary thyroid microcarcinoma.

LIU Chang, LIU Hui, B Cong, YAO Xi-Yu, WU Yu… - …, 2021 - search.ebscohost.com
… management of papillary thyroid microcarcinoma (… cN0 papillary thyroid microcarcinoma
patients and provide advice for surgical strategies. The clinicopathological features of 556 cN0

[HTML][HTML] Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta …

X Wen, Q Jin, X Cen, M Qiu, Z Wu - World journal of surgical oncology, 2022 - Springer
… for poorer prognosis and recurrence in papillary thyroid microcarcinoma (PTMC). However,
the clinicopathologic factors for CLNM in clinical node-negative (CN0) PTMC were not well …

[HTML][HTML] The application value of the Central Lymph Node Metastasis Risk Assessment Model in Papillary thyroid Microcarcinoma of Stage cN0: a study of 828 patients

J Wang, X Sheng, Y Dai, J Zhang, L Song… - Frontiers in …, 2022 - frontiersin.org
… Background: The aim of this study is to build a risk assessment system for central lymph
node metastasis (CLNM) in papillary thyroid microcarcinoma (PTMC) of stage cN0 and to …

Can less Be more in the treatment of cN1a papillary thyroid microcarcinoma?

P Zmijewski, LE Kuo - The American Journal of …, 2022 - americanjournalofsurgery.com
… the risk of recurrence was no different between cN1a and cN0 patients, although the study
was … with papillary thyroid microcarcinoma with cN1a nodal staging could benefit from thyroid

[HTML][HTML] A model based on ultrasound and clinical factors to predict central lymph node metastasis in cN0 papillary thyroid microcarcinoma

S Sun, Q Zhou, T Hu - Heliyon, 2024 - cell.com
… Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): …
central lymph node metastasis in preoperative patients with cN0 papillary thyroid cancer. …

[HTML][HTML] Prophylactic central neck dissection for cN0 papillary thyroid carcinoma: is there any difference between western countries and China? A systematic review …

J Yang, Y Han, Y Min, C Chen, J Chen… - Frontiers in …, 2023 - frontiersin.org
… ) treatment, and thyroid-stimulating hormone (TSH) inhibition therapy (5). As the most common
type of differentiated thyroid carcinoma (DTC), papillary thyroid carcinoma (PTC) exhibits …